LECAP Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,413
Closed -$679K 319
2025
Q3
$679K Buy
12,413
+3,626
+41% +$181K 0.24% 167
2025
Q2
$467K Buy
+8,787
New +$446K 0.17% 213
2025
Q1
Sell
-8,075
Closed -$454K 324
2024
Q4
$454K Sell
8,075
-630
-7% -$39.2K 0.12% 231
2024
Q3
$593K Buy
+8,705
New +$491K 0.13% 244
2024
Q2
Sell
-14,830
Closed -$1.02M 345
2024
Q1
$1.02M Buy
+14,830
New +$938K 0.21% 173

Other funds holding EXAS

LECAP Asset Management's EXAS Position: Q4 2025 in Review

LECAP Asset Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 12,413 shares — an estimated $679K sold.

LECAP Asset Management first reported a position in EXAS in Q1 2024 and held it in 5 quarters. The position peaked at $1.02M in Q1 2024. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • LECAP Asset Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • LECAP Asset Management sold 12,413 Exact Sciences shares in Q4 2025, an estimated $679K.
  • LECAP Asset Management first reported a position in Exact Sciences in Q1 2024 and held it in 5 quarters.
  • LECAP Asset Management's Exact Sciences position peaked at $1.02M in Q1 2024.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on LECAP Asset Management's 13F filing for Q4 2025, filed 27 Jan 2026.